New-look Sarepta eyes approval for muscular dystrophy drug
(Reuters) - After three decades without bringing a drug to market, Sarepta Therapeutics Inc stands on the verge of a breakthrough with its treatment f...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/e95YvLvAdPs/story01.htm
No comments:
Post a Comment